OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Improving these processes involves fine-tuning various factors, including cell line development, media ingredients, and bioreactor settings. A key goal is to increase antibody yield while reducing production costs an